Financhill
Sell
33

IMVT Quote, Financials, Valuation and Earnings

Last price:
$26.16
Seasonality move :
-30.75%
Day range:
$25.82 - $26.75
52-week range:
$12.72 - $27.69
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
8.82x
Volume:
1.1M
Avg. volume:
1.7M
1-year change:
1.67%
Market cap:
$4.6B
Revenue:
--
EPS (TTM):
-$2.83

Earnings Data

Next earnings date for IMVT
Feb 05
2026
Most recent earnings per share
-$0.73
Missed by $0.00
(Nov 10/2025)
Consensus Estimate
-$0.73
(Nov 10/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

IMVT Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
02/05/2026 Q4 -- -- -- -$0.70 --
11/10/2025 Q3 -- -- -$0.73 -$0.73 -$0.00
08/11/2025 Q2 -- -- -$0.71 -$0.67 -$0.03
05/28/2025 Q1 -- -- -$0.64 -$0.72 $0.08
02/06/2025 Q4 -- -- -$0.76 -$0.75 -$0.00
11/07/2024 Q3 -- -- -$0.75 -$0.61 -$0.14
08/06/2024 Q2 -- -- -$0.60 -$0.52 -$0.08
05/29/2024 Q1 -- -- -$0.52 -$0.43 -$0.09
02/12/2024 Q4 -- -- -$0.36 -$0.42 $0.06
11/09/2023 Q3 -- -- -$0.45 -- --
08/10/2023 Q2 -- -- -$0.57 -- --
05/22/2023 Q1 -- -- -$0.46 -- --
02/03/2023 Q4 -- -- -$0.49 -- --
11/04/2022 Q3 -- -- -$0.41 -- --
08/05/2022 Q2 -- -- -$0.35 -- --
06/08/2022 Q1 -- -- -$0.41 -- --
02/04/2022 Q4 -- -- -$0.36 -- --
11/05/2021 Q3 -- -- -$0.35 -- --
08/06/2021 Q2 -- -- -$0.31 -- --
06/01/2021 Q1 -- -- -$0.29 -- --
02/16/2021 Q4 -- -- -$0.32 -- --
11/12/2020 Q3 -- -- -$0.25 -- --
08/12/2020 Q2 -- -- -$0.38 -- --
06/29/2020 Q1 -- -- -$0.38 -- --
02/14/2020 Q4 -- -- -$0.28 -- --
09/30/2019 Q3 -- -- $0.01 -- --
08/12/2019 Q2 -- -- $0.01 -- --
06/12/2019 Q1 -- -- -$0.00 -- --

Immunovant, Inc. Earnings Questions

  • How Much did Immunovant, Inc. Generate in Revenue Last Quarter?

    Immunovant, Inc. reported -- worth of top line sales in its most recent quarter.

  • Did Immunovant, Inc. Beat Earnings Last Quarter?

    Immunovant, Inc. announced earnings per share of -$0.73 which represents a miss of analyst forecast a -$0.73 per share.

  • Is Immunovant, Inc. Profitable?

    Immunovant, Inc. reported -$105K that represents -$0.00 per share over the last quarter.

  • What is the Analyst Consensus for Immunovant, Inc. EPS Next Year?

    Immunovant, Inc.'s earnings are forecast to decrease from -$2.73 per share to -$2.87 per share next year representing a decrease of -7.18%.

  • When is Immunovant, Inc.'s Earnings Date?

    Immunovant, Inc.'s next earnings date is February 5, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Stock Ideas

Buy
59
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 65x

Buy
55
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
72
GLTO alert for Dec 27

Galecto, Inc. [GLTO] is up 16.92% over the past day.

Sell
20
SMX alert for Dec 27

SMX (Security Matters) Plc [SMX] is down 15.76% over the past day.

Sell
11
CDNAF alert for Dec 27

Canadian Tire Corp. Ltd. [CDNAF] is down 10% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock